🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06824376
Recruiting Not applicable

Manual Acupuncture (MA) for Asymptomatic Hyperuricemia (HUA)

NCT06824376 · tracked via the Priya Life Science China tracker
Sponsor
Shenghao Tu
Phase
Not applicable
Started
2025-03-25
Last updated
2025-03-30

Condition(s) studied

Asymptomatic Hyperuricemia

Investigational drug(s) / intervention(s)

Manual acupunctureSham acupuncture

Manual acupuncture: After sterilisation, the sharp needles will be inserted into the deep tissue layers of acupoints. Acupuncturists will tried to elicit acupuncture de-qi sensation by the manual manipulation of needles. Within a 30-minute period, manual manipulation for each acupoint will last at least 10 seconds and wil repeated four times with intervals of 10-minute.

Sham acupuncture: After sterilisation, Streitberger placebo needles with blunt tip will be used. It can be fixed on the surface of the sham points without piercing the skin. Within a 30-minute period, each point will undergo a simulated twisting motion of the needle for at least 10 seconds, and this will be repeated four times at 10-minute intervals.

Study summary

Assess the effectiveness of manual acupuncture in modulating serum uric acid levels among patients diagnosed with asymptomatic hyperuricemia.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * With serum uric acid (SUA) level \>7 mg/dL after 1 month of a low-purine diet. * No history of gouty arthritis. * Has not received uric acid-lowering drug treatment or stopped uric acid- lowering drug treatment ≥ 12 weeks. * 18.5kg/m2 ≤ body mass index (BMI) ≤ 30.0 kg/m2. * Can write informed consent. Exclusion Criteria: * Patients with poorly controlled hypertension: systolic blood pressure (SBP) ≥ 160mmHg, diastolic blood pressure (DBP) ≥ 100 mmHg. * Patients with poorly controlled diabetes (hemoglobin A1c ≥ 8.4%). * Patients with severe liver and kidney damage: chronic kidney disease (CKD) ≥ stage 2 or a serum creatinine, urea, alanine, or aspartate aminotransferase level more than twice of the upper limit. * Patients with blood system diseases, such as acute and chronic leukemia, polycythemia, multiple myeloma, hemolytic anemia, lymphoma, or undergoing chemotherapy for multiple solid tumors. * Patients with stroke, coronary heart disease, or severe neuropsychological diseases. * Patients who are pregnant. * Illiterate or unwilling to accept acupuncture treatment.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Institute of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan Hubei Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06824376 on ClinicalTrials.gov ↗ ← All trials in China